Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
04/2012
04/03/2012US8147802 Chelator-functionalized nanoparticles
04/03/2012US8147801 Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion
04/03/2012US8147798 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
04/03/2012CA2339066C Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
03/2012
03/29/2012WO2012040513A1 Compositions and methods for the delivery of beta lapachone
03/29/2012WO2012040108A2 Multivalent fluorescent probes
03/29/2012WO2012038489A1 Vascular imaging agents
03/29/2012WO2012013756A3 Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol
03/29/2012WO2012006038A3 Agents and compounds for imaging and other applications, and methods of use and synthesis thereof
03/29/2012WO2011143128A3 Multi-phasic nanostructures for imaging and therapy
03/29/2012WO2011140519A3 In vivo gelling pharmaceutical pre-formulation
03/29/2012WO2011140517A9 Methods for treating diseases of the lung
03/29/2012US20120076737 Method of using ct/mri dual modality contrast agent
03/29/2012US20120076736 Host supported genetic biosensors
03/29/2012US20120076735 Nanoparticles for Extravascular Administration
03/29/2012US20120076734 Radiopaque antibiotic dental paste and uses thereof
03/29/2012US20120076733 Post-biopsy cavity treatment implants and methods
03/29/2012US20120076732 Phosphodiesterase inhibitors and uses thereof
03/29/2012US20120076731 Lymphedema associated genes and model
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012US20120076729 Methods of treating cancers
03/29/2012US20120076728 Human protein scaffold with controlled serum pharmacokinetics
03/28/2012EP2433726A1 CT/MRI dual-modality molecular imaging contrast agent and method for manufacturing the same
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2432483A1 Composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases
03/28/2012EP2432460A1 Water dispersible glyceryl monooleate magnetic nanoparticle formulation
03/28/2012EP2432458A2 Ingestible event markers comprising an ingestible component
03/28/2012EP2146749B1 Labelled hgf binding peptides for imaging
03/28/2012EP1859041B1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
03/28/2012CN102391874A NaYF4-based fluorescent nano particles with double effects and preparation method thereof
03/28/2012CN102389576A Magnetic-ultrasonic difunctional SiO2 hollow sphere contrast agent and preparation method and application thereof
03/27/2012US8143013 Visible to near-infrared light probe using energy transfer between luciferase and an organic dye via a sugar chain
03/27/2012US8142762 Methods of using GPR101 receptors to identify modulators of hypothalamic proopiomelanocortin (POMC)-derived biologically active peptide secretion
03/27/2012US8142761 Method of predicting spot formation on the skin using spot site-accelerating genes as an indicator thereof and method of screening inhibitors of spot formation on the skin
03/27/2012US8142760 Vaccination for Lawsonia intracellularis
03/27/2012CA2282721C A transgenic coagulation factor xiii defective animal and its use for testing wound healing and bleeding
03/22/2012WO2012036697A1 Micro devices biomedical applications and uses of the same
03/22/2012WO2011133925A3 Targeted and light-activated cytosolic drug delivery
03/22/2012WO2011122770A9 Magnetic resonance imaging contrast agent coated with polymer having mannose-modified terminal, and preparation method thereof
03/22/2012WO1996002235A9 Injectable res avoiding inorganic particles
03/22/2012US20120073002 Prevention and treatment of blood coagulation-related disases
03/22/2012US20120073001 Methods and compositions for treating or preventing pruritis
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070383 Polymeric nano-carriers with a linear dual response mechanism and uses thereof
03/22/2012US20120070382 Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof
03/22/2012US20120070381 Ophthalmologic composition having gelation ability
03/22/2012US20120070380 Ingestible salt grabber
03/22/2012US20120070379 Immunotherapy regimes dependent on apoe status
03/22/2012US20120070378 Lanthanide ion complexes and imaging method
03/22/2012US20120070377 Compounds and biological materials and uses thereof
03/22/2012US20120070376 Yeast cell wall particles for receptor-targeted nanoparticle delivery
03/22/2012US20120070375 Complex and contrast agent for photoimaging using the same
03/22/2012DE102010045797A1 Verbindungen für die Diagnostik neurodegenerativer Erkrankungen am Riechepithel Compounds for the diagnosis of neurodegenerative diseases of the olfactory epithelium
03/22/2012CA2812189A1 Micro devices for biomedical applications and uses of the same
03/21/2012EP2431054A2 Human tumor necrosis factor delta and epsilon
03/21/2012EP2429593A2 Biomolecule complexes as contrast agents in positron emission tomography (pet) based methods for the assessment of organ function
03/21/2012EP2429591A1 Fluorescent phospholipid ether compounds, compositions, and methods of use
03/21/2012EP2429590A1 Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form
03/21/2012EP2429589A2 Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine
03/21/2012EP2429588A2 Measurement of body fluid volumes
03/21/2012EP1616193B1 MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs)
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012CN102380110A SiO2 hollow sphere ultrasonic imaging contrast agent material and preparation method and application thereof
03/21/2012CN102380109A Magnetic resonance contrast agent constructed by amphipathic polysaccharide-wrapped super-paramagnetic nanoparticles and preparation method thereof
03/21/2012CN102380108A Quick-hardening contrast agent special for defecography
03/21/2012CN102380107A Method for detecting whether patient is allergic to medicine
03/21/2012CN102380106A Hemi-parkinsonism monkey model and medicament screening method thereof
03/21/2012CN102380105A Method utilizing nude mice to provide reference for scientific drug administration of tumour patients
03/21/2012CN102379873A Acute general Parkinson's disease monkey model and medicament screening method thereof
03/21/2012CN102379685A Automatic pain analysis system
03/21/2012CN101805738B Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof
03/21/2012CN101272808B Optical imaging
03/20/2012US8138143 Methods for treating a neurological disorder by peripheral administration of a trophic factor
03/20/2012US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/20/2012US8137679 Immunogen adherence inhibitor directed to Lactobacillus organisms and method of making and using it
03/20/2012CA2455455C Method and system to determine revised dosage
03/20/2012CA2392453C Modulation of signal transduction
03/15/2012WO2012033901A2 Somatostatin receptor-based cancer therapy
03/15/2012WO2012032524A1 Near infrared fluorescent particles and uses thereof
03/15/2012WO2011150212A3 Magnetic nanoparticles
03/15/2012WO2011133773A3 Compositions and methods for leukocyte-targeting multi-valent imaging probes
03/15/2012WO2011026808A8 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
03/15/2012US20120066777 Test agent for visceral obesity and use thereof
03/15/2012US20120065614 Polyionic transitional metal phosphorescent complex/polymer hybrid systems for bioimaging and sensing applications
03/15/2012US20120064012 Uniform Fluorescent Microspheres with Hydrophobic Surfaces
03/15/2012US20120064011 Preparation for external application
03/15/2012US20120064010 CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration
03/15/2012US20120064009 Methods of leukemia cell detection
03/15/2012US20120064008 Compositions for the treatment of metastatic cancer and methods of use thereof
03/15/2012US20120064007 Methods of using sustained release aminopyridine compositions
03/15/2012US20120064006 Systems and methods for using physiological information
03/15/2012US20120064001 Anti-VEGF Antibody Compositions and Methods
03/15/2012US20120064000 Human Monoclonal Antibodies Against Hendra And Nipah Viruses
03/15/2012US20120063999 Psca: prostate stem cell antigen and uses thereof
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012CA2810838A1 Somatostatin receptor-based cancer therapy
03/14/2012EP2428231A2 Biomolecule complexes as contrast agents in Positron Emission Tomography (PET) based methods for the assessment of organ function
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 354